Shervin Assassi
Division Director · University of Texas Health Science Center at Houston
Credentials: · · · · ·
History
The University of Texas Health Science Center at Houston (UTHealth) McGovern Medical School
- 1995–1999
ALBERT-LUDWIGS-UNIV, FREIBURG
Research
The Lancet Respiratory Medicine · 2016 · 831 citations
Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis
New England Journal of Medicine · 2014 · 375 citations
Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus
Nature Genetics · 2010 · 312 citations
131 papers
55 papers
40 papers
38 papers
34 papers
33 papers
30 papers
28 papers
Grants
- 2026–2031
Hypoxia-Driven NUDT21-Mediated APA Promotes Lung and Skin Fibrosis in Systemic Sclerosis
National Institute of Arthritis and Musculoskeletal and Skin Diseases · R01
PI · $623.3K · University of Texas Hlth Sci Ctr Houston
- 2026–2030
Mechanisms of Response to CD19 Redirected PluriReceptor NK Cells in Systemic Autoimmunity
National Institute of Arthritis and Musculoskeletal and Skin Diseases · R01
Contact PI · $421K · University of Texas Hlth Sci Ctr Houston
- 2023–2028
National Institute of Arthritis and Musculoskeletal and Skin Diseases · R01
Contact PI · $1.1M · University of Texas Hlth Sci Ctr Houston
- 2020–2025
National Institute of Arthritis and Musculoskeletal and Skin Diseases · R33
Contact PI · $388.5K · University of Texas Hlth Sci Ctr Houston
Clinical trials
- 2017–2018
Optical Elastography of Systemic Sclerosis Skin
Principal investigator · Completed
The University of Texas Health Science Center, Houston
- 2024–2030
Site PI · Recruiting · Phase 1, Phase 2
M.D. Anderson Cancer Center